176 related articles for article (PubMed ID: 12542523)
1. The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis.
Asano Y; Ihn H; Yamane K; Kubo M; Tamaki K
J Invest Dermatol; 2003 Feb; 120(2):204-10. PubMed ID: 12542523
[TBL] [Abstract][Full Text] [Related]
2. A new conformational epitope generated by the binding of recombinant 70-kd protein and U1 RNA to anti-U1 RNP autoantibodies in sera from patients with mixed connective tissue disease.
Murakami A; Kojima K; Ohya K; Imamura K; Takasaki Y
Arthritis Rheum; 2002 Dec; 46(12):3273-82. PubMed ID: 12483732
[TBL] [Abstract][Full Text] [Related]
3. Further characterization and subcellular localization of Sm and U1 ribonucleoprotein antigens.
Habets WJ; Berden JH; Hoch SO; Van Venrooij WJ
Eur J Immunol; 1985 Oct; 15(10):992-7. PubMed ID: 2414112
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.
Margaux J; Hayem G; Palazzo E; Chazerain P; De Bandt M; Haim T; Kahn MF; Meyer O
Rev Rhum Engl Ed; 1998 Jun; 65(6):378-86. PubMed ID: 9670329
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.
Combe B; Rucheton M; Graafland H; Lussiez V; Brunel C; Sany J
Clin Exp Immunol; 1989 Jan; 75(1):18-24. PubMed ID: 2702772
[TBL] [Abstract][Full Text] [Related]
6. The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease.
Dima A; Jurcut C; Baicus C
Rheumatol Int; 2018 Jul; 38(7):1169-1178. PubMed ID: 29796907
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease.
Ikeda K; Takasaki Y; Hirokawa K; Takeuchi K; Hashimoto H
J Rheumatol; 2003 May; 30(5):998-1005. PubMed ID: 12734895
[TBL] [Abstract][Full Text] [Related]
8. [Clinical expression of systemic lupus erythematosus with anti-U1-RNP and anti-Sm antibodies].
López-Longo FJ; González Fernández CM; Rodríguez Mahou M; Grau Simó R; Monteagudo Sáez I; Meno García AC; Carreño Pérez L
Rev Clin Esp; 1997 May; 197(5):329-35. PubMed ID: 9280966
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies in systemic sclerosis.
Steen VD
Semin Arthritis Rheum; 2005 Aug; 35(1):35-42. PubMed ID: 16084222
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune response to U1 small nuclear ribonucleoprotein (U1 snRNP) associated with cytomegalovirus infection.
Newkirk MM; van Venrooij WJ; Marshall GS
Arthritis Res; 2001; 3(4):253-8. PubMed ID: 11438044
[TBL] [Abstract][Full Text] [Related]
11. Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease.
Sato T; Fujii T; Yokoyama T; Fujita Y; Imura Y; Yukawa N; Kawabata D; Nojima T; Ohmura K; Usui T; Mimori T
Arthritis Rheum; 2010 Dec; 62(12):3730-40. PubMed ID: 20722023
[TBL] [Abstract][Full Text] [Related]
12. Doubtful Clinical Value of Subtyping Anti-U1-RNP Antibodies Regarding the RNP-70 kDa Antigen in Sera of Patients with Systemic Lupus Erythematosus.
Ahmad A; Brylid A; Dahle C; Saleh M; Dahlström Ö; Enocsson H; Sjöwall C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373545
[TBL] [Abstract][Full Text] [Related]
13. Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis.
Chevalier K; Chassagnon G; Leonard-Louis S; Cohen P; Dunogue B; Regent A; Thoreau B; Mouthon L; Chaigne B
J Autoimmun; 2024 Jun; 146():103220. PubMed ID: 38642508
[TBL] [Abstract][Full Text] [Related]
14. Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease.
Ghirardello A; Doria A; Vesco P; Vaccaro E; Bernardi C; Catani C; Fagiolo U; Gambari PF
Rheumatol Int; 1996; 16(4):145-50. PubMed ID: 8961378
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of U1-RNP immune complexes in mixed connective tissue disease and systemic lupus erythematosus.
Negoro N; Kanayama Y; Takeda T; Amatsu K; Koda S; Inoue Y; Kim T; Okamura M; Inoue T
Rheumatol Int; 1987; 7(1):7-11. PubMed ID: 2954202
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody recognition of distinctly modified forms of the U1-70-kd antigen is associated with different clinical disease manifestations.
Greidinger EL; Casciola-Rosen L; Morris SM; Hoffman RW; Rosen A
Arthritis Rheum; 2000 Apr; 43(4):881-8. PubMed ID: 10765934
[TBL] [Abstract][Full Text] [Related]
17. [Immunologic tests: Anti-RNP . Sm antibodies (anti-U1 RNP antibodies)].
Kaburaki J
Nihon Rinsho; 2005 Jul; 63 Suppl 7():483-5. PubMed ID: 16111308
[No Abstract] [Full Text] [Related]
18. Clinical significance of IgG subclasses of Anti-Sm and U1 ribonucleoprotein antibodies in patients with systemic lupus erythematosus and mixed connective tissue disease.
Tokano Y; Yasuma M; Harada S; Takasaki Y; Hashimoto H; Okumura K; Hirose S
J Clin Immunol; 1991 Nov; 11(6):317-25. PubMed ID: 1837028
[TBL] [Abstract][Full Text] [Related]
19. [Low prevalence of anti-centromere antibodies in scleroderma in Morocco (about 272 cases)].
Admou B; Arji N; Seghrouchni F; Missoum H; El Fenniri L; Amghar S; El Aouad R
Ann Biol Clin (Paris); 2007; 65(3):291-7. PubMed ID: 17502303
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
Faria AC; Barcellos KS; Andrade LE
J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
